<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <link rel="icon" href="Conferimgs/visioneurLogoHigh.png" type="image/x-icon">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Home - VISION EUROPE 2030</title>

    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Sofia">
    <link href="https://fonts.googleapis.com/css?family=Montserrat:700" rel="stylesheet">

    <link href="https://fonts.googleapis.com/css2?family=Poppins:wght@400;600;700&display=swap" rel="stylesheet">

    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <link rel="stylesheet" href="css/styles.css">
    <link rel="stylesheet" href="css/followup.css">
    <link rel="stylesheet" href="css/voice.css">
    <script src="js/cookies.js"></script>
    <!-- Cloudflare Web Analytics -->
    <script defer src='https://static.cloudflareinsights.com/beacon.min.js'
        data-cf-beacon='{"token": "3858608a60aa47b5b23f7d6b8fd8d862"}'></script><!-- End Cloudflare Web Analytics -->
</head>

<body>

    <div class="cookie-popup" id="cookie-popup">
        <div class="cookie-content">
            <p>The VISION EUROPE website uses only essential cookies required for its functioning. Analytics
                tools may be used in anonymised form to monitor website traffic and improve services. Users
                can opt out of non-essential cookies where applicable.</p>
            <button id="accept-cookies">Accept</button>
        </div>
    </div>

    <!-- Header -->
    <header>
        <div class="logo">
            <div style="display: flex; flex-direction: row; align-items: center;"><img
                    src="Conferimgs/visioneurLogoHigh.png" style="padding-left: 10px; width: 60px; height: auto;"><a
                    href="index.html" style="color: #333333;"></a>
            </div>
            <button onclick="MobileHamBurgerMenu()"><i class="fa fa-bars hamico"></i></button>
        </div>

        <nav id="nav-menu">
            <ul>
                <li><a href="index.html">Home</a></li>
                <li><a href="about.html">About</a></li>
                <li><a href="#">Follow Up Activities</a></li>
                <li><a href="agenda.html">Programme & Sessions</a></li>
                <li><a href="speakers.html">Speakers & Moderators</a></li>
            </ul>
        </nav>
    </header>

    <section class="section-container">
        <h1 class="section-title">Building on VISION EUROPE 2030: an Overview of the Conference’s Follow-Up Activities
        </h1>
        <p class="para" style="text-align: justify;">
            Following the Brussels conference, VISION EUROPE 2030 continued its discourse globally, extending the
            conversations and collaborations initiated during the two-day event. Between September and November 2025,
            high-level meetings were held in <b>New York, Japan, Oman and China</b>, highlighting how Europe’s policy,
            innovation, and health systems intersect with global efforts in precision oncology and non-communicable
            disease prevention.
        </p>
        <p class="para" style="text-align: justify;">
            These follow-up activities focused on translating pilot projects into system-level change, fostering
            international collaboration, and ensuring that innovations reach patients worldwide. Key objectives
            included:
        <ul class="unorderd-list para">
            <li>Sharing knowledge and insights from the Brussels conference, supporting global alignment on early
                detection, vaccination, and precision treatments.</li>
            <li>Engaging regional partners in Oman, Japan, and China to explore local implementation strategies,
                workforce development, and regulatory frameworks.</li>
            <li>Promoting evidence-based adoption of advanced diagnostics, AI-driven decision support, and integrated
                care, ensuring innovations are accessible and equitable.</li>
            <li>Documenting outcomes through interviews, recordings, and social media content, creating a reusable
                knowledge library for policymakers, clinicians, and researchers.</li>
        </ul>
        </p>
        <p class="para" style="text-align: justify;">
            These follow-up activities underline VISION EUROPE 2030’s mission: closing the “last mile” between
            scientific potential and real-world impact, ensuring that precision medicine, advanced diagnostics, and
            patient-centred care are implemented efficiently, consistently, and equitably across Europe and beyond.

        </p>

        <div>
            <h1 class="section-title margin-top-followup blue">United States – New York</h1>
            <p class="para" style="text-align: justify;">
                At the end of September, VISION EUROPE 2030 started extending its discussions beyond Europe to explore
                how innovations in cancer and non-communicable diseases (NCDs) can be translated into tangible global
                impact. The “Last Mile Series”, held in New York in September 2025, consisted of three high-level
                events, each building on the insights from Brussels and forming a unified call to close the gap between
                scientific potential and real-world access.
            </p>
            <p class="para" style="text-align: justify;">
                The series opened at the Italian Cultural Institute, with the
                event titled “The Last Mile – Screening, Early Detection and Treatment: Driving Investment, Innovation,
                and Alignment.” Leading speakers and delegates, including <b>Phil Hogan, Roberto Grasso, Adda Bounedjar,
                    Josep Figueras, Hesham Elghazaly and Zisis Kozlakidis</b>, all key speakers at Vision Europe 2030 in
                Brussels, examined how strategic investment, coordinated implementation, and cross-sector cooperation
                can accelerate access to prevention, early detection, and treatment. This event set the stage for a
                global campaign aimed at translating evidence-based policy into practical action, reinforcing Vision
                Europe’s commitment to equitable and timely innovation.
                The second event, titled “The Last Mile: Bridging the Cancer & NCD Innovation Gap with AI, Early
                Detection and Equitable Access”, took place at the United Nations Headquarters and was co-hosted by the
                Permanent Mission of the Philippines. This session brought Vision Europe’s priorities into the heart of
                multilateral diplomacy, emphasizing the urgency of equitable access to innovation across regions.
                Participants highlighted the value of aligned governance, collaborative financing models, and
                data-driven strategies to ensure that breakthroughs in cancer and NCD care reach all populations.
                <b>Kara
                    Alikpala</b>, who served as moderator for the session, helped guide discussions and facilitate
                dialogue
                among international delegates. Strong engagement from international delegates validated the global
                relevance of Vision Europe’s agenda.
            </p>
            <p class="para" style="text-align: justify;">
                The series concluded with a high-level luncheon at the
                Permanent Mission of Switzerland to the United Nations, bringing together distinguished leaders such as
                <b>Ruggero De Maria and Josep Figueras</b>, who both were present in Brussels and played a central role
                in the
                New York discussions, but also new speakers who added to the conversation: among them Harold Varmus, who
                received the Nobel Prize for Medicine in 1989, and <b>Jonathan A. Lal</b>, from SHUATS University,
                India. The
                conversation focused on the central challenge of implementing innovation across cancer, NCDs, and rare
                diseases, highlighting the importance of sustainable financing, equitable access, and coordinated
                international efforts.
            </p>
        </div>

        <div>
            <h1 class="section-title margin-top-followup blue">Japan – Yokohama</h1>
            <p class="para" style="text-align: justify;">
                Held in Yokohama, this follow-up event focused on translating world-class scientific capability into
                everyday clinical benefit. Titled “From Pipeline to Patient: Delivering on the Promise of Precision
                Oncology and Beyond”, the meeting explored how Japan can convert consensus into near-term action across
                early detection, stratified screening, real-world evidence, clinical trials, and sustainable financing.
            </p>
            <p class="para" style="text-align: justify;">
                Building on the VISION EUROPE 2030 agenda, discussions emphasized the need for robust governance
                frameworks, interoperable data systems, value-based reimbursement, workforce capacity, patient literacy,
                and responsible use of AI. Japan’s experience demonstrated feasible pathways for standardized testing,
                minimal residual disease (MRD) deployment, and data-driven oncology, showing how scientific
                breakthroughs can be translated into practical, equitable care.
            </p>
            <p class="para" style="text-align: justify;">The Yokohama Forum also served as the next step following the
                New York sessions, where a broad coalition of governments, UN agencies, development banks, industry,
                academia, and patient organizations endorsed the “Consensus Framework: The Last Mile Action Agenda”.
                This framework outlined three shared priorities:
            <ul class="unorderd-list para">
                <li>Equitable early detection – embedding genomics, AI, and innovative screening approaches into
                    healthcare systems.</li>
                <li>Strengthening partnerships and capacity – empowering countries through workforce development,
                    education, and collaboration.</li>
                <li>Mobilizing sustainable financing – creating innovative models for reimbursement, access, and
                    resilient health systems.</li>
            </ul>
            </p>
            <p class="para" style="text-align: justify;">
                Political and technical discussions underscored that innovation without delivery risks deepening
                inequities. Speakers like <b>Denis Horgan</b> highlighted practical models that can shorten the distance
                between evidence and patient benefit. By convening leading clinicians, scientists and policymakers, this
                follow-up event aligned with the broader goals of VISION EUROPE 2030, reinforcing the commitment to
                equitable access to innovation, stronger cancer systems, and meaningful improvements for patients, not
                only in Europe but worldwide.
                
            </p>
            <p style="text-align: left;">
                <a href="Data/JAPAN From Pipeline to Patient_ Delivering on the Promise of Precision Oncology and Beyond.docx.pdf" class="agenda-btn" target="_blank">View Agenda</a>
            </p>
        </div>

        <div>
            <h1 class="section-title margin-top-followup blue">Oman – Muscat</h1>
            <p class="para" style="text-align: justify;">
                The VISION EUROPE 2030 follow-up event in Muscat, Oman, titled “Advancing Translational Education:
                Regional Strategies for Precision Medicine in the MENA Region”, brought together regional partners to
                discuss tailored implementation strategies for the Gulf and neighbouring regions. Held under the theme
                “Global Unity for Cancer Prevention: Empowering Communities” during the World Cancer Congress 2025, the
                forum provided a major platform to advance the VISION EUROPE agenda, strengthen global partnerships, and
                reduce disparities in cancer care.
            </p>
            <p class="para" style="text-align: justify;">
                Discussions focused on building sustainable screening and vaccination programs adapted to local
                epidemiology and healthcare infrastructures, strengthening workforce capacity, and designing regulatory
                and financing frameworks that reflect regional realities. Participants explored how training,
                communication, and regional cooperation can prepare health systems for precision medicine, translating
                global best practices into actionable local strategies. Speakers addressed key areas such as workforce
                development, patient navigation, and operational readiness for advanced diagnostics and therapies. The
                event emphasized that equitable access to innovation requires not only technology but also education,
                capacity building, and sustained collaboration between regional and global stakeholders.
            </p>
            <p class="para" style="text-align: justify;">
                The Oman meeting reinforced the overarching VISION EUROPE 2030 message: global strategies succeed only
                when they are carefully adapted to regional contexts, ensuring tangible impact and practical
                implementation in diverse health systems.
            </p>
            <p style="text-align: left;">
                <a href="Data/PDF Agenda, Advancing Transational Education (Oman)-2.pdf" class="agenda-btn" target="_blank">View Agenda</a>
            </p>
        </div>

        <div>
            <h1 class="section-title margin-top-followup blue">China – Kunming</h1>
            <p class="para" style="text-align: justify;">
                At the CACA–ICPC Summit in Kunming, global leaders convened to explore how artificial intelligence and
                digital tools can enhance, rather than replace, person-centred cancer care. The summit built on the
                foundations of VISION EUROPE 2030, reinforcing the principle that technology must serve patients and
                professionals, supporting care without compromising human connection.
            </p>
            <p class="para" style="text-align: justify;">
                Speakers including <b>Daniela Chieffo</b>, who also played a key role at VISION EUROPE 2030 in Brussels,
                where she set the scene for the session “Precision Frontiers in Chronic Disease – A Global Strategy for
                Cancer Risk, Trials and Treatment, stressed that technological innovation must remain anchored in
                compassion, ethics, and patient partnership. Discussions focused on integrating psycho-oncological
                support into high-tech care pathways, deploying AI responsibly with fairness, explainability, and
                transparency, and establishing governance, reimbursement, privacy, and infrastructure frameworks that
                enable equitable access.
            </p>
            <p class="para" style="text-align: justify;">
                A second session connected European and global policy efforts, highlighting cross-border collaboration,
                education, and infrastructure development as critical enablers for delivering human-centred, ethically
                sound care. The Kunming summit showcased the global resonance of Vision Europe’s core principles:
                ethical innovation, equity in access, and putting patients at the centre of every decision,
                demonstrating that technological advances must be matched by thoughtful implementation and societal
                readiness.
            </p>
            <p style="text-align: left;">
                <a href="Data/CACA-ICPC Summit - DH.docx (1).pdf" class="agenda-btn" target="_blank">View Agenda</a>
            </p>
        </div>
        <div>
            <h1 class="section-title margin-top-followup blue">Looking Ahead</h1>
            <p class="para" style="text-align: justify;">
                From Brussels to New York, Yokohama, Muscat and Kunming, the 2025 meetings have converged on the same
                conclusion: the decisive challenge for this decade is not discovering more technologies, but delivering
                what we already have – fairly, consistently and at scale.
            </p>
        </div>

    </section>

    <!-- Footer -->
    <footer>
        <div class="logo-area">
            <img src="Conferimgs/eapmlogo_white.png" alt="VISION Europe 2030 Logo white">
            <p>In a world that’s increasingly interconnected and diverse, EAPM is dedicated to spearheading a
                new era in healthcare — one where precision and personalization redefine the standards of
                prevention and treatment strategies. Join us in exploring the forefront of medical innovation,
                where our commitment to individualized care is not just a goal but a revolution.</p>
        </div>
        <hr>
        <div class="social-links-area">
            <h1>Contact Us</h1>
            <p>If you have any questions or need more information about VISION EUROPE 2030, please reach out to us:</p>

            <a class="email-btn" href="mailto:denishorgan@euapm.eu"><i class="fa-solid fa-paper-plane"></i> E-mail
                Us</a>

            <div class="office-addr">
                <h2>Office</h2>
                <p><b>European Alliance For Personalized Medicine</b><br>
                    Avenue de l’Armee Legerlaan 10 1041 Brussels</p>
            </div>

            <!-- <h1>Media Centres & Social Hub</h1>
            <div class="media-centres">
                <a>Gallery</a>
                <a>News</a>
                <a>Press Releases</a>
                <a>Interview highlights</a>
            </div> -->

            <section class="box-links-follow">
                <section style="width:100%">
                    <h1>Go Back To</h1>
                    <div class="go-back-links">
                        <a href="index.html">Home</a>
                        <a href="about.html">About</a>
                        <a href="agenda.html">Agenda</a>
                        <a href="privacy.html">Privacy Policy</a>
                    </div>

                </section>
                <section>
                    <h1>Follow Us</h1>
                    <div class="social-links">
                        <a href="https://x.com/euapmbrussels?ref_src=twsrc%5Etfw" target="_blank"><i
                                class="fab fa-twitter"></i></a>
                        <a href="https://www.linkedin.com/company/european-alliance-for-personalised-medicine-eapm/"
                            target="_blank"><i class="fab fa-linkedin-in"></i></a>
                        <a href="https://www.youtube.com/@EUAPM-YouTube" target="_blank"><i
                                class="fab fa-youtube"></i></a>
                    </div>
                    <p style="text-align: justify;">
                        <img src="Conferimgs/Co-fundedEU_POS.jpg" alt="EU4Health"
                            style="width: 90%; height: auto;"></img><br>
                        <b>Co-funded by the European Union.</b></br>
                        Views and opinions expressed are however those of the author(s) only and do not necessarily
                        reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA).
                        Neither the European Union nor the granting authority can be held responsible for them.
                    </p>
                    <p>&copy; 2024 EAPM. All rights reserved.</p>
                </section>

        </div>

        </div>
    </footer>
    <button id="scrollToTopBtn" title="Go to top"><i class="fa-solid fa-arrow-up" style="font-size: 30px;"></i></button>
    <script>

        // Get the button element
        const scrollToTopBtn = document.getElementById("scrollToTopBtn");

        // When the user scrolls down 20px from the top of the document, show the button
        window.onscroll = function () {
            if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
                scrollToTopBtn.style.display = "block";
            } else {
                scrollToTopBtn.style.display = "none";
            }
        };

        // When the user clicks on the button, scroll to the top of the document
        scrollToTopBtn.addEventListener("click", function () {
            window.scrollTo({
                top: 0,
                behavior: "smooth"
            });
        });

        function MobileHamBurgerMenu() {
            var x = document.getElementById("nav-menu");
            if (x.style.display === "block") {
                x.style.display = "none";
            } else {
                x.style.display = "block";
            }
        }

    </script>

</body>

</html>